{"id":"https://openalex.org/W4393085166","doi":"https://doi.org/10.1158/1538-7445.am2024-4476","title":"Abstract 4476: Novel auristatins with improved tolerability and unique bystander activity profile","display_name":"Abstract 4476: Novel auristatins with improved tolerability and unique bystander activity profile","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393085166","doi":"https://doi.org/10.1158/1538-7445.am2024-4476"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-4476","doi":"https://doi.org/10.1158/1538-7445.am2024-4476","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-4476","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4393085166"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086477832","display_name":"Philip N. Moquist","orcid":"https://orcid.org/0000-0001-6378-6408","observed_orcids":["https://orcid.org/0000-0001-6378-6408"]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip N. Moquist","raw_affiliation_strings":["1Seagen, Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Seagen, Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5094221854","display_name":"Nicole M.-L. Eng-Duncan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole M. Eng-Duncan","raw_affiliation_strings":["1Seagen, Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Seagen, Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067420985","display_name":"Tim D. Bovee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tim Bovee","raw_affiliation_strings":["1Seagen, Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Seagen, Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002326187","display_name":"Katie Snead","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katie Snead","raw_affiliation_strings":["1Seagen, Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Seagen, Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108910892","display_name":"Jenn Wright","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jenn Wright","raw_affiliation_strings":["1Seagen, Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Seagen, Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009207751","display_name":"Kaleb Smith","orcid":"https://orcid.org/0000-0002-4362-1240","observed_orcids":["https://orcid.org/0000-0002-4362-1240"]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kaleb Smith","raw_affiliation_strings":["1Seagen, Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Seagen, Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111152298","display_name":"Teri Blevins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Teri Blevins","raw_affiliation_strings":["1Seagen, Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Seagen, Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111152299","display_name":"Brittney Blackburn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brittney Blackburn","raw_affiliation_strings":["1Seagen, Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Seagen, Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019036090","display_name":"Michelle L. Ulrich","orcid":"https://orcid.org/0009-0004-3010-8212","observed_orcids":["https://orcid.org/0009-0004-3010-8212"]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Ulrich","raw_affiliation_strings":["1Seagen, Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Seagen, Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026933112","display_name":"Forgivemore Magunda","orcid":"https://orcid.org/0000-0001-7854-5818","observed_orcids":["https://orcid.org/0000-0001-7854-5818"]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Forgivemore Magunda","raw_affiliation_strings":["1Seagen, Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Seagen, Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022798732","display_name":"Jessica K. Simmons","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Simmons","raw_affiliation_strings":["1Seagen, Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Seagen, Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089318759","display_name":"Peter D. Senter","orcid":"https://orcid.org/0000-0003-2748-6007","observed_orcids":["https://orcid.org/0000-0003-2748-6007"]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter D. Senter","raw_affiliation_strings":["1Seagen, Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Seagen, Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103551444","display_name":"Svetlana O. Doronina","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Svetlana O. Doronina","raw_affiliation_strings":["1Seagen, Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Seagen, Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I99319750"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"4476","last_page":"4476"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.36649999022483826,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.36649999022483826,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.21080000698566437,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.06889999657869339,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/auristatin","display_name":"auristatin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9980000257492065},{"id":"https://openalex.org/keywords/off-target-toxicity","display_name":"off-target toxicity","score":0.621999979019165},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.7210000157356262},{"id":"https://openalex.org/keywords/lipophilicity","display_name":"lipophilicity","score":0.734000027179718},{"id":"https://openalex.org/keywords/cell-membrane-permeability","display_name":"cell membrane permeability","score":0.718999981880188},{"id":"https://openalex.org/keywords/tubulin-binding","display_name":"tubulin binding","score":0.8669999837875366},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.7099999785423279}],"concepts":[{"id":"https://openalex.org/C19106626","wikidata":"https://www.wikidata.org/wiki/Q230749","display_name":"Bystander effect","level":2,"score":0.9242476224899292},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8009940981864929},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5182235240936279},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2544698715209961},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.09971696138381958},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.08193790912628174}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-4476","doi":"https://doi.org/10.1158/1538-7445.am2024-4476","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-4476","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4411554950","https://openalex.org/W2886511670","https://openalex.org/W4410237109","https://openalex.org/W2962021985","https://openalex.org/W3093094945","https://openalex.org/W4393075747","https://openalex.org/W2148127139","https://openalex.org/W3029419287","https://openalex.org/W1901302412","https://openalex.org/W3007430974"],"abstract_inverted_index":{"Abstract":[0],"Auristatins":[1],"are":[2,17],"a":[3,97,102,177],"class":[4],"of":[5,32,57,104,135,160,165,238],"clinically":[6],"validated":[7],"payloads":[8,44],"used":[9],"extensively":[10],"in":[11,40,115,147,152,157,166,169],"antibody-drug":[12],"conjugate":[13],"(ADC)":[14],"technology.":[15],"There":[16],"currently":[18],"4":[19],"FDA":[20],"approved":[21],"ADCs":[22,63,148],"utilizing":[23],"the":[24,88,121,133,158,239],"vedotin":[25],"drug":[26,179],"linker":[27,180],"to":[28,71,119,128],"treat":[29],"an":[30,185],"array":[31],"solid":[33],"tumors":[34],"and":[35,37,55,74,92,110,117,131,173,187,230],"lymphomas":[36],"several":[38,46],"more":[39],"clinical":[41],"trials.":[42],"Auristatin":[43],"have":[45,64],"desirable":[47],"properties,":[48],"including":[49],"strong":[50,189],"anticancer":[51],"cytotoxicity,":[52],"bystander":[53,136,162,171,232],"activity,":[54,172],"induction":[56],"immunologic":[58],"cell":[59,122],"death.":[60],"While":[61],"auristatin-based":[62],"been":[65],"remarkably":[66],"successful,":[67],"there":[68],"remain":[69],"opportunities":[70],"further":[72],"understand":[73],"improve":[75],"payload":[76],"properties.":[77],"Bystander":[78],"activity":[79,137,233],"is":[80],"one":[81],"such":[82],"property":[83],"that":[84,113,181],"can":[85],"greatly":[86],"impact":[87,134],"balance":[89],"between":[90],"efficacy":[91],"tolerability.":[93],"Herein,":[94],"we":[95],"present":[96],"medicinal":[98],"chemistry":[99],"investigation":[100],"into":[101],"series":[103],"auristatins":[105,226],"with":[106,149,227],"similar":[107,150],"tubulin":[108],"binding":[109],"biochemical":[111],"potency":[112],"differ":[114],"lipophilicity":[116],"ability":[118],"cross":[120],"membrane.":[123],"This":[124],"design":[125],"enabled":[126],"us":[127],"focus":[129],"on":[130],"characterize":[132],"while":[138],"maintaining":[139],"all":[140],"other":[141],"parameters.":[142],"Ultimately,":[143],"this":[144],"effort":[145],"resulted":[146],"on-target":[151],"vitro":[153],"cytotoxicity":[154],"but":[155],"differed":[156],"extent":[159],"off-target":[161],"activity.":[163],"Evaluation":[164],"vivo":[167,170],"efficacy,":[168],"rodent":[174],"tolerability":[175,229],"afforded":[176],"lead":[178],"was":[182],"well-tolerated":[183],"as":[184],"ADC":[186],"exhibited":[188],"antitumor":[190],"growth":[191],"delay.":[192],"Citation":[193],"Format:":[194],"Philip":[195],"N.":[196],"Moquist,":[197],"Nicole":[198],"M.":[199],"Eng-Duncan,":[200],"Tim":[201],"Bovee,":[202],"Katie":[203],"Snead,":[204],"Jenn":[205],"Wright,":[206],"Kaleb":[207],"Smith,":[208],"Teri":[209],"Blevins,":[210],"Brittney":[211],"Blackburn,":[212],"Michelle":[213],"Ulrich,":[214],"Forgivemore":[215],"Magunda,":[216],"Jessica":[217],"Simmons,":[218],"Peter":[219],"D.":[220],"Senter,":[221],"Svetlana":[222],"O.":[223],"Doronina.":[224],"Novel":[225],"improved":[228],"unique":[231],"profile":[234],"[abstract].":[235],"In:":[236],"Proceedings":[237],"American":[240],"Association":[241],"for":[242],"Cancer":[243,261],"Research":[244],"Annual":[245],"Meeting":[246],"2024;":[247],"Part":[248],"1":[249],"(Regular":[250],"Abstracts);":[251],"2024":[252],"Apr":[253],"5-10;":[254],"San":[255],"Diego,":[256],"CA.":[257],"Philadelphia":[258],"(PA):":[259],"AACR;":[260],"Res":[262],"2024;84(6_Suppl):Abstract":[263],"nr":[264],"4476.":[265]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-03-23T00:00:00"}